Influence of Brain Insulin Sensitivity on Peripheral Insulin Sensitivity
NCT01847456 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10
Last updated 2013-12-23
Summary
The researchers will investigate if brain insulin action influences peripheral insulin sensitivity in healthy humans.
Conditions
- Insulin Sensitivity
Interventions
- DRUG
-
human insulin as nasal spray
- DRUG
Sponsors & Collaborators
-
University Hospital Tuebingen
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- SINGLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 35 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2013-04-30
- Primary Completion
- 2013-11-30
Countries
- Germany
Study Locations
More Related Trials
-
Effect of Empagliflozin Versus Placebo on Brain Insulin Sensitivity in Patients With Prediabetes
NCT03227484 ·Status: COMPLETED ·Phase: PHASE2
-
Dose-Dependent Effect of Intranasal Insulin in Humans Using Functional Magnetic Resonance Imaging (fMRI)
NCT06144255 ·Status: COMPLETED ·Phase: PHASE1
-
Influence of Central Nervous Insulin Action on Insulin Sensitivity of Peripheral Organs in Lean Versus Overweight Humans
NCT02468999 ·Status: COMPLETED ·Phase: NA
-
Effect of GLP1 Receptor Agonist on Brain Insulin Responsiveness
NCT06487832 ·Status: RECRUITING ·Phase: NA
-
Insulin Deprivation on Brain Structure and Function in Humans With Type 1 Diabetes
NCT03392441 ·Status: COMPLETED ·Phase: NA
-
Relative Contribution of Brain Insulin Action for Postprandial Metabolism
NCT06295640 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Enhancement of Cerebral Vasoreactivity and Cognition by Intranasal Insulin in Type 2 Diabetes
NCT01206322 ·Status: COMPLETED ·Phase: PHASE2
-
Regulation of Endogenous Glucose Production by Brain Insulin Action in Insulin Resistance
NCT03383822 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Raclopride-PET/MRT
NCT03637075 ·Status: COMPLETED ·Phase: NA
-
Improving Insulin Sensitivity by Non-invasive Brain Stimulation
NCT04420650 ·Status: COMPLETED ·Phase: NA
-
Effect of GLP-1 on Glucose Metabolism in CNS Assessed by PET
NCT01185119 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Improving Insulin Sensitivity by Non-invasive Brain Stimulation in Persons With Insulin Resistance
NCT04052399 ·Status: UNKNOWN ·Phase: NA
-
The Effect of GLP-1 on Glucose Uptake in the Brain and Heart in Healthy Men During Hypoglycemia
NCT00418288 ·Status: COMPLETED ·Phase: NA
-
The Effect of GLP-1 on Glucose Uptake in the Brain and Heart in Healthy Men
NCT00256256 ·Status: COMPLETED ·Phase: NA
-
Glucagon Enhanced Insulin Absorption in Diabetes Mellitus Type 1
NCT05960565 ·Status: TERMINATED ·Phase: PHASE2
-
Impact of Dopamine Infusion on Insulin Secretion in Healthy Subjects
NCT02053935 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Insulin Glulisine vs Regular Human Insulin on Postprandial Endothelial Function in Type 2 Diabetes
NCT00562133 ·Status: COMPLETED ·Phase: PHASE3
-
The Effect of Intranasal Insulin on Hepatic and Intestinal Triglyceride-rich Lipoprotein Production
NCT03141827 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Incretin Hormones in Type-1 Diabetes Mellitus Glycemic Response in Type-1 Diabetes Mellitus
NCT00832741 ·Status: COMPLETED
-
Development of Agents to Diminish the Risk of Hypoglycemia-induced Brain Injury in Type 1 Diabetes
NCT03356457 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Effect of LY2189265 on Insulin Secretion in Response to Intravenous Glucose
NCT01300260 ·Status: COMPLETED ·Phase: PHASE1
-
Insulin Action: Role of Skeletal Muscle and Insulin-Mediated Blood Flow
NCT00018304 ·Status: COMPLETED
-
Impact of INsulin Sensitivity on Cardiovascular Risk Markers During 10-20 Years of FOllow up
NCT01412554 ·Status: COMPLETED
-
Effect of Intranasal Insulin on Cognitive Processes and Appetite
NCT03632681 ·Status: COMPLETED ·Phase: NA
-
Beneficial Effect of Insulin Glulisine by Lipoatrophy and Type 1 Diabetes (LAS)
NCT02914886 ·Status: COMPLETED ·Phase: PHASE4